Postherpetic Neuralgia

A Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Postherpetic Neuralgia (RELIEFPHN1) (Post Shingles Pain).

Sign Up For A Study

    Study Information

    Condition

    Postherpetic Neuralgia

    Phase II

    Conquest Research needs volunteers for an investigational trial evaluating a medication designed to help treat patients suffering from Postherpetic Neuralgia. You may qualify if you:

    • Are at least 18 years of age

    • Presence of pain after the healing of shingles

    Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

    Sign Up For A Study

      What To Expect

      PATIENT RESOURCES & FAQ

      Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

      SEE MORE
      A mature medical doctor smiling as some of his colleagues stand in the background

      Register For A Study!

      Register